We are monitoring the impact of COVID-19 on Europe Metabolomics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3320
Share on
Share on

Europe Metabolomics Market Research Report - Segmented By Product, Indication, Application & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, & Forecast To 2024

Pulished: February, 2020
ID: 3320
Pages: 175

Europe Metabolomics Market Size & Growth (2019-2024):

As Per the Report, the Europe Metabolomics Market is valued at USD 530 Million in 2019 and estimated to grow at a CAGR of 18.4%, to reach USD 1240 Million by 2024 during the forecast period 2019-2024.

Metabolomics is the considerable scale research of minute molecules, usually known as metabolites, inside cells, tissues or living beings. Aggregately, these tiny particles and their associations inside an organic framework are known as the metabolome. Therefore metabolomics characterizes the microscopic phenotype. Metabolomics is a skilled approach since metabolites and their concentration not like other "omics" measures, directly reflect the hidden biochemical movement and state of cells. The Europe Metabolomics market is emerging at an exceptionally quick speed.

Govt. financing and private funding are also reassuring the growth of this market. Metabolomics is in effect gradually sought after as they help in shrinking the hole between genotype and phenotype by offering a whole perspective of the cell working. Stable innovative advances and looks into will guarantee a proceeded with the development of this market and will decrease the effect of these restrictions in the future. Nonetheless, the unexplored markets in evolving countries will spur new progress open doors for market players.

This research report on the Europe Metabolomics Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

  • By Product: GC, Bioinformatics, Mass Spectrometry, HPLC, UPLC, NMRS, Surface-based mass analysis
  • By Indication: Oncology, Cardiology, Inborn Error.
  • By Application: Nutrigenomics, Toxicology, Biomarker & Drug Discovery.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe.

On the Basis of Application, the Biomarker Discovery segment had the largest share in 2016 in the global metabolomics market. Efficiency and reliability have been cited as the reason for the growth of biomarkers. However collaboration between biotechnology and pharmaceutical companies, the personalized medical segment is expected to have the highest CAGR.

On the Basis of the Region, Europe had the least CAGR during the forecast period. The reasons for the same might be government policies.

Top Companies leading the Europe Metabolomics Market Profiled in the Report are Agilent Technologies, Inc. (U.S.), Human Metabolome Technologies, Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), LECO Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), Danaher Corporation (U.S.), Biocrates Life Sciences AG (Austria), and Waters Corporation (U.S.) are the leaders in the North America Metabolomics market

1.Introduction                

1.1 Market Definition  

1.2 Study Deliverables

1.3 Base Currency, Base Year and Forecast Periods        

1.4 General Study Assumptions                                

2. Research Methodology                         

2.1 Introduction             

2.2 Research Phases    

 2.2.1 Secondary Research                           

 2.2.2 Primary Research                 

 2.2.3 Econometric Modelling                      

 2.2.4 Expert Validation                  

2.3 Analysis Design       

2.4 Study Timeline        

3. Overview                     

3.1 Executive Summary                                

3.2 Key Inferences       

3.3 Epidemology            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                  

4.1 Market Drivers        

4.2 Market Restraints  

4.3 Key Challenges       

4.4 Current Opportunities in the Market            

5. Market Segmentation                            

5.1 Product      

 5.1.1 Metabolomic Instruments                               

              5.1.1.1Separation Techniques   

              5.1.1.1.1 Gas Chromatography (GC)

              5.1.1.1.2 Capillary Electrophoresis (CE)

              5.1.1.1.3 High-performance Liquid Chromatography (HPLC)

              5.1.1.1.4 Ultra-performance Liquid Chromatography (UPLC)

              5.1.1.2 Detection Tools 

              5.1.1.2.1 Mass Spectrometry

              5.1.1.2.2 Nuclear Magnetic Resonance Spectroscopy

              5.1.1.2.3 Surface-Based Mass Analysis

 5.1.2 Metabolomics Bioinformatics Tools and Services                   

              5.1.2.1 Bioinformatics Tools & Databases              

              5.1.2.2 Bioinformatics Services  

 5.1.3 Y-o-Y Growth Analysis, By Product                               

 5.1.4 Market Attractiveness Analysis, By Product                             

 5.1.5 Market Share Analysis, By Product                               

5.2 Indication  

 5.2.1 Cancer                      

 5.2.2 Cardiovascular Disorders                   

 5.2.3 Inborn errors                         

 5.2.4 Neurological Errors                              

 5.2.5 Other Indications                 

 5.2.4 Y-o-Y Growth Analysis, By Indication                           

 5.2.5 Market Attractiveness Analysis, By Indication                         

 5.2.6 Market Share Analysis, By Indication                           

5.3 Application                                 

 5.3.1 Nutrigenomics                       

 5.3.2 Toxicology                               

 5.3.3 Biomarker & Drug Discovery                            

 5.3.4 Functional Genomics                          

 5.3.5 Personalized Medicine                      

 5.3.6 Other Applications

 5.3.7 Y-o-Y Growth Analysis, By Application                         

 5.3.8 Market Attractiveness Analysis, By Application                       

 5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis                            

6.1 Introduction             

 6.1.1 Regional Trends                    

 6.1.2 Impact Analysis                     

 6.1.3 Y-o-Y Growth Analysis                        

              6.1.3.1 By Geographical Area     

              6.1.3.2 By Product           

              6.1.3.3 By Indication       

 6.1.4 Market Attractiveness Analysis                      

              6.1.4.1 By Geographical Area     

              6.1.4.2 By Product           

              6.1.4.3 By Indication       

 6.1.5 Market Share Analysis                       

              6.1.5.1 By Geographical Area     

              6.1.5.2 By Product           

              6.1.5.3 By Indication       

6.2 U.K                                 

6.3 Spain           

6.4 Germany   

6.5 Italy             

6.6 France        

7.Strategic Analysis                      

7.1 PESTLE analysis       

 7.1.1 Political                     

 7.1.2 Economic                 

 7.1.3 Social                         

 7.1.4 Technological                         

 7.1.5 Legal                          

 7.1.6 Environmental                       

7.2 Porter’s Five analysis            

 7.2.1 Bargaining Power of Suppliers                        

 7.2.2 Bargaining Power of Consumers                    

 7.2.3 Threat of New Entrants                     

 7.2.4 Threat of Substitute Products and Services                              

 7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                       

8.1 Waters Corporation (U.S.) 

 8.1.1 Overview                 

 8.1.2 Product Analysis                   

 8.1.3 Financial analysis                  

 8.1.4 Recent Developments                       

 8.1.5 SWOT analysis                       

 8.1.6 Analyst View                          

8.2 Agilent Technologies, Inc. (U.S.)      

8.3 Human Metabolome Technologies, Inc. (Japan)      

8.4 Thermo Fisher Scientific, Inc. (U.S.)                                 

8.5 LECO Corporation (U.S.)      

8.6 Bruker Corporation (U.S.)  

8.7 Shimadzu Corporation (Japan)         

8.8 Metabolon Inc. (U.S.)          

8.9 Danaher Corporation (U.S.)                                 

8.10 Biocrates Life Sciences AG (Austria)            

9.Competitive Landscape                          

9.1 Market share analysis          

9.2 Merger and Acquisition Analysis     

9.3 Agreements, collaborations and Joint Ventures       

9.4 New Product Launches       

10.Market Outlook and Investment Opportunities                        

Appendix                         

a) List of Tables                                

b) List of Figures            

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Metabolomics Market By Product, From 2019-2024 ( USD Million )
  2. Europe GC Market By Region, From 2019-2024 ( USD Million )
  3. Europe Bioinformatics Market By Region, From 2019-2024 ( USD Million )
  4. Europe Mass Spectroscopy Market By Region, From 2019-2024 ( USD Million )
  5. Europe HPLC Market By Region, From 2019-2024 ( USD Million )
  6. Europe UPLC Market By Region, From 2019-2024 ( USD Million )
  7. Europe NMRS Market By Region, From 2019-2024 ( USD Million )
  8. Europe Surface Based analysis Market By Region, From 2019-2024 ( USD Million )
  9. Europe Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  10. Europe Oncology Market By Region, From 2019-2024 ( USD Million )
  11. Europe Cardiology Market By Region, From 2019-2024 ( USD Million )
  12. Europe Inborn Errors Market By Region, From 2019-2024 ( USD Million )
  13. Europe Metabolomics Market By Application, From 2019-2024 ( USD Million )
  14. Europe Nutrigenomics Market By Region, From 2019-2024 ( USD Million )
  15. Europe Toxicology Market By Region, From 2019-2024 ( USD Million )
  16. Europe Biomarker & Drug Discovery Market By Region, From 2019-2024 ( USD Million )
  17. U.K. Metabolomics Market By Product, From 2019-2024 ( USD Million )
  18. U.K. Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  19. U.K. Metabolomics Market By Application, From 2019-2024 ( USD Million )
  20. Germany Metabolomics Market By Product, From 2019-2024 ( USD Million )
  21. Germany Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  22. Germany Metabolomics Market By Application, From 2019-2024 ( USD Million )
  23. France Metabolomics Market By Product, From 2019-2024 ( USD Million )
  24. France Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  25. France Metabolomics Market By Application, From 2019-2024 ( USD Million )
  26. Italy Metabolomics Market By Product, From 2019-2024 ( USD Million )
  27. Italy Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  28. Italy Metabolomics Market By Application, From 2019-2024 ( USD Million )
  29. Spain Metabolomics Market By Product, From 2019-2024 ( USD Million )
  30. Spain Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  31. Spain Metabolomics Market By Application, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample